Stefano Boi

Stefano is a Research fellow in the Cell Engineering Group working on a collaboration with Allergan Ltd. where they will examine novel approaches to improve the production and characterisation of Adeno-associated virus as a vector for gene therapies. In his previous postdoctoral experience Stefano spent 5 years at the Rocky Mountain Laboratories (National Institute of Health, National Institute of Allergy and Infectious Diseases) in Hamilton, Montana. During his postdoc he worked on different projects regarding the interaction between endogenous and exogenous mouse retroviruses, the restriction by mouse APOBEC3 of Murine Leukaemia Virus, the phenomenon of retroviral latency observed in chronically infected cells and the phenomenon of retroviral interference between ecotropic viruses in vivo. He received a PhD focused on research and development of new antiviral drugs in 2014 at the University of Cagliari, in Sardinia, where he also obtained his master’s and bachelor’s degree in Experimental and Applied Biology